TVARDI THERAPEUTICS, INC. Increase (Decrease) in Inventories
TVARDI THERAPEUTICS, INC. (TVRD) reported Increase (Decrease) in Inventories of $1.04 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2025-05-13
- TVARDI THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2024-12-31 was $729.00K.
- TVARDI THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2024-09-30 was $1.00K.
- TVARDI THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2024-06-30 was $392.00K.
- TVARDI THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2024-03-31 was -$80.00K, a 107.07% decline year-over-year.
- TVARDI THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2024 was $1.04M, a 137.90% increase from fiscal 2023.
- TVARDI THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2023 was $438.00K.
- TVARDI THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2022 was -$201.00K, a 107.78% decline from fiscal 2021.
- TVARDI THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2021 was $2.58M.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2024-12-31 | $729.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $730.00K derived: sum of 2 quarters · filed 2025-03-11 | $1.12M derived: sum of 3 quarters · filed 2025-03-11 | $1.04M 10-K · filed 2025-03-11 |
| 2024-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $393.00K derived: sum of 2 quarters · filed 2024-11-14 | $313.00K 10-Q · filed 2024-11-14 | -$132.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-06-30 | $392.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $312.00K 10-Q · filed 2024-08-14 | -$133.00K derived: sum of 3 quarters · filed 2025-05-13 | -$287.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-03-31 | -$80.00K 10-Q · filed 2025-05-13 | -$525.00K derived: sum of 2 quarters · filed 2025-05-13 | -$679.00K derived: sum of 3 quarters · filed 2025-05-13 | -$774.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$445.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$599.00K derived: sum of 2 quarters · filed 2025-03-11 | -$694.00K derived: sum of 3 quarters · filed 2025-03-11 | $438.00K 10-K · filed 2025-03-11 |
| 2023-09-30 | -$154.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$249.00K derived: sum of 2 quarters · filed 2024-11-14 | $883.00K 10-Q · filed 2024-11-14 | $1.43M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | -$95.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.04M 10-Q · filed 2024-08-14 | $1.58M derived: sum of 3 quarters · filed 2025-03-11 | -$40.00K derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $1.13M 10-Q · filed 2024-05-13 | $1.68M derived: sum of 2 quarters · filed 2025-03-11 | $55.00K derived: sum of 3 quarters · filed 2025-03-11 | $1.61M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | $548.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$1.08M derived: sum of 2 quarters · filed 2025-03-11 | $476.00K derived: sum of 3 quarters · filed 2025-03-11 | -$201.00K 10-K · filed 2025-03-11 |
| 2022-09-30 | -$1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$72.00K derived: sum of 2 quarters · filed 2023-11-13 | -$749.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $876.00K 10-Q · filed 2023-08-07 | ||
| 2022-03-31 | -$677.00K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $2.58M 10-K · filed 2024-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |